Perioperative genitourinary infection associated with sodium-glucose co-transporter 2 inhibitor use

Perioperative genitourinary infection associated with sodium-glucose co-transporter 2 inhibitor use

Context: Sodium-glucose co-transporter 2 (SGLT-2) inhibitors are a novel treatment approved for type 2 diabetes mellitus to lower hyperglycemia, systolic blood pressure, and promote weight loss. Commonly reported serious adverse events include increased mycotic urogenital infections, orthostatic hyp...

Full beskrivning

Bibliografiska uppgifter
Huvudupphovsmän: Stephen Melnick, Priya Rajagopalan, Theresa Lynn, Anthony Donato
Materialtyp: Artikel
Språk:English
Publicerad: Greater Baltimore Medical Center 2018-09-01
Serie:Journal of Community Hospital Internal Medicine Perspectives
Ämnen:
Sodium glucose co-transporter inhibitor
SGLT2 inhibitor
genitourinary infections
Länkar:http://dx.doi.org/10.1080/20009666.2018.1527667

Internet

http://dx.doi.org/10.1080/20009666.2018.1527667

Liknande verk